Skip to main content

Next-Generation Vaccines Eradicating Chronic and Infectious Diseases


The growing prevalence of chronic and infectious disorders such as cancer, and diabetes, globally has emerged as the biggest concerns that the medical industry faces today. There have been continuous attempts to develop improved treatment procedures for such diseases.
Vaccines have been one of the most effective methods for the treatment and prevention of diseases. The invention of DNA, recombinant, and cancer vaccines, and advancements in the platform for vaccine delivery have transformed the conventional therapeutic and preventive vaccines and are playing an important role in the treatment of such chronic diseases.
At present, the vaccine market is in its growing stage, however as per the market intelligence report published by BIS Research titled “Global Vaccine Market – Analysis and Forecast (2018 – 2028),” the vaccine market is anticipated to witness tremendous growth at 11.0% during the forecast period, 2018 – 2028 and generate $103.57 billion in the revenue by 2028.
This high growth of the market can be attributed to the increasing incidences of chronic diseases, growing adoption of vaccines across developed as well as developing countries, and the invention of advanced techniques and technologies.  Amongst the long list of advantages of vaccines, the reduced healthcare cost and improved life expectancy rate are their major benefits.
Several leading pharmaceutical companies are venturing in the market, some of these include Abbott Laboratories, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Johnson & Johnson, Merck & Company Inc., and Madison Vaccines Incorporated.
The report published by BIS Research discusses the vaccine market under different segments on the basis of type, disease type, and region. Under the vaccine type, there are subunit and conjugate, live attenuated, inactivated, recombinant, toxoid, and next-generation vaccines. Moreover, the disease type segment includes cancer, hepatitis, rotavirus, varicella, and influenza, among others.
Under the region segment, the report analyzes the market for North America, Europe, Asia-Pacific, Latin America, and Middle East Africa. Amongst these, Asia-Pacific region is expected to grow at the fastest CAGR during the forecast period.
With technological advancements in the medical industry, vaccines for multiple cancers such as gastric, ovarian, melanoma, and prostate cancer have already been developed and several companies at present are focusing to develop next-generation vaccines. The global vaccine market in the coming years is expected to evolve and undergo various developments and advancements.

Comments

Post a Comment

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...
2 comments
Read more

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...
1 comment
Read more

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...
1 comment
Read more